CORONA Remedies Limited (CORONA) reported revenue of ₹422 Cr and net profit of ₹60.11 Cr for the quarter ended 2026-06-30. Figures are parsed from the company's filed results.
CORONA fundamentals, Fundamental score 93/100
The statements below are read from CORONA Remedies Limited’s filed results, 8 filed quarters and 4 fiscal years on record, consolidated basis. Price-linked ratios are computed at the last close, sector medians across the served universe, ownership from the shareholding pattern, and any cell whose input isn’t on record shows a dash, never an estimate.
Latest: Q1 FY26-27 · filed Aug 1, 2026 · audited
Sales CAGR · 3Y+16.7%FY22 → FY25
Sales CAGR · 4Y——
PAT CAGR · 3Y+29.6%FY22 → FY25
PAT CAGR · 4Y——
Price · 1Y—EOD
Price CAGR · 3Y—EOD
Quarterly resultsConsolidated
₹ Cr
Sep2024
Dec2024
Mar2025
Jun2025
Sep2025
Dec2025
Mar2026
Jun2026Latest
YoYlatest
Sales
314
298
294
347
361
342
353
422
+21.7%
247
228
239
277
283
259
291
329
+18.9%
Operating profit
67.0
70.0
55.0
70.0
78.5
83.2
62.0
93.1
+33.0%
OPM %
21.3%
23.5%
18.7%
20.2%
21.7%
24.3%
17.6%
22.0%
+1.9 pp
Other income
2.00
1.00
2.00
2.00
2.27
2.24
4.11
3.15
+57.5%
Interest
3.00
2.00
2.00
2.00
1.93
1.66
1.38
2.69
+34.5%
Depreciation
9.00
10.0
10.0
9.00
9.20
9.45
10.3
13.2
+47.1%
Profit before tax
57.0
58.0
44.0
61.0
69.6
55.2
54.7
80.4
+31.7%
Tax %
24.6%
22.4%
27.3%
24.6%
25.1%
25.2%
17.2%
25.2%
+0.6 pp
Net profit
43.0
45.0
32.0
46.0
52.3
41.3
45.3
60.1
+30.7%
EPS (₹)
7.03
7.35
5.16
7.55
8.55
6.75
7.41
9.83
+30.2%
One column per filed quarter · ₹ crore · YoY = latest vs the same quarter a year back · EPS restated for bonus/split↔ scroll for earlier quarters
Revenue & net profit trend
last 8 quarters
RevenueNet profit
Revenue & net profit — Consolidated8 quarters
Segment results
Needs segment dataSegment results not parsedPer-segment revenue, EBIT margin and YoY arrive once we parse the segment annexure from the filing.
Forensic checksauto-scanned from the filing
Coming soonForensic checks not connectedAuditor opinion, OCF÷PAT, contingent liabilities, related-party share and working-capital days arrive as we parse the notes-to-accounts + cash-flow statement. Promoter-pledge is already on the Holdings tab.
How results moved the priceEOD reaction on the session the market could trade the filing
Avg absolute result-day move ±3.0%· EPS surprise: no estimates source· 4 earlier quarters have no dated filing on record
